NCT05044338

Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease

China Degenerative Valve Disease II Cohort Study (China-DVD2 Study)

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 6,000 (estimated)
• Sponsor: Yongjian Wu · Other Government
• Sex: All
• Age: 65 Years
• Healthy volunteers: —

Summary

The key technology research and standard evaluation system of elderly heart valve disease evaluation is to further establish a domestic multi center and large sample full information big data platform of elderly heart valve disease based on the previous Chinese elderly valve disease cohort and clinical research platform and the national valve disease surgery data platform.

Detailed description

Establish clinical and Imaging Database

Conditions

• Valvular Heart Disease

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	imaging	(1) Build the first full information big data cloud platform for diagnosis, treatment and clinical research of senile valvular disease in China (2) To establish a cohort of elderly patients with valvular disease in China and a complete database covering clinical information, functional, imaging evaluation, treatment and follow-up; (3) To analyze the clinical characteristics, functional status and imaging characteristics of senile valvular disease in China, and to understand the current situation of diagnosis and treatment; To establish a whole process standardized comprehensive evaluation system of clinical indicators of senile valvular disease combined with a variety of imaging for Chinese people.

Timeline

• Start date: 2021-09-01
• Primary completion: 2023-11-01
• Completion: 2023-11-01
• First posted: 2021-09-14
• Last updated: 2021-09-16

Locations

1 site across 1 country: China